Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 5 , Pages 491-495 , September 2009

Preoperative hydronephrosis as an indicator of survival after radical cystectomy

  • Darren M. Chapman, M.D.

      Affiliations

    • Department of Urology, The Ohio State University, Columbus, OH 43210, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-614-293-8155; fax: +1-614-293-3565
    • ,
  • Kamal S. Pohar, M.D.

      Affiliations

    • Department of Urology, The Ohio State University, Columbus, OH 43210, USA
    • ,
  • Michael C. Gong, M.D., Ph.D.

      Affiliations

    • Department of Urology, Cleveland Clinic, Cleveland, OH 44195, USA
    • ,
  • Robert R. Bahnson, M.D.

      Affiliations

    • Department of Urology, The Ohio State University, Columbus, OH 43210, USA

Received 2 February 2008 ,Revised 8 June 2008 ,Accepted 10 June 2008.

References 

  1. Novara G, Ficarra V, Alrabi N, et al. Prognostic factors in a recent series of patients treated with radical cystectomy for bladder cancer. Urol Int. 2005;75:10–16
  2. Quek ML, Stein JP, Nichols PW, et al. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. J Urol. 2005;174:103–106
  3. Lotan Y, Gupta A, Shariat SF, et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 1005;23:6533–9.
  4. Haleblian GE, Skinner EC, Dickinson MG, et al. Hydronephrosis as a prognostic indicator in bladder cancer patients. J Urol. 1998;160:2011–2014
  5. Liebovitch I, Ben-Chaim J, Ramon J, et al. The significance of ureteral obstruction in invasive transitional cell carcinoma of the urinary bladder. J Surg Oncol. 1993;52:31–35
  6. Bartsch GC, Kuefer R, Gschwend JE, et al. Hydronephrosis as a prognostic marker in bladder cancer in a cystectomy-only series. Eur Urol. 2007;51:690–698
  7. Scrimger RA, Murtha AD, Parliament MB, et al. Muscle-invasive transitional cell carcinoma of the urinary bladder: A population-based study of patterns of care and prognostic factors. Int J Rad Oncol Biol Phys. 2001;51:23–30
  8. Bassi P, Ferrante GD, Piazza N, et al. Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort. J Urol. 1999;161:1494–1497
  9. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol. 2001;19:666–675
  10. Karakiewicz PI, Shariat SF, Palapattu GS, et al. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. J Urol. 2006;176:1354–1362
  11. Herr H. The concept of lymph node density—is it ready for clinical practice?. J Urol. 2007;177:1273–1275
  12. Koppie TM, Vickers AJ, Vora K, et al. Standardization of pelvic lymphadenectomy performed at radical cystectomy. Cancer. 2006;107:2368–2374
  13. Thrasher JB, Frazier HA, Robertson JE, et al. Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer. 1994;73:1708–1715
  14. Yang MH, Yen CC, Chen PM, et al. Prognostic factors based risk stratification model for invasive urothelial carcinoma of the urinary bladder in Taiwan. Urology. 2002;59:232–238
  15. Ficarra V, Dalpiaz O, Alrabi N, et al. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma. Br J Urol Int. 2005;95:786–790
  16. Dutta SC, Smith JA, Shappell SB, et al. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol. 2001;166:490–493

PII: S1078-1439(08)00151-8

doi: 10.1016/j.urolonc.2008.06.001

Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 5 , Pages 491-495 , September 2009

Article Tools

* Image Usage & Resolution